Clinical Trial Update: Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of BI 10773 in combination with insulin in patients with Type 2 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 10773
• Insulin (insulin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-09-30